Ignite Creation Date:
2025-12-25 @ 12:00 AM
Ignite Modification Date:
2026-03-05 @ 1:05 AM
Study NCT ID:
NCT01894958
Status:
COMPLETED
Last Update Posted:
2018-02-05
First Post:
2013-07-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
Sponsor:
Neuren Pharmaceuticals Limited
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
Neu-2566-FXS-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None